28-Aug-2026
TipRanks (Tue, 25-Aug 10:45 AM ET)
TipRanks (Tue, 25-Aug 8:40 AM ET)
Globe Newswire (Tue, 25-Aug 7:00 AM ET)
Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Mon, 17-Aug 4:28 PM ET)
Globe Newswire (Thu, 13-Aug 7:00 AM ET)
Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Globe Newswire (Tue, 11-Aug 7:30 AM ET)
Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
Globe Newswire (Tue, 4-Aug 7:00 AM ET)
Sagimet Biosciences Joins the Russell 2000 and Russell 3000 Indexes
Globe Newswire (Mon, 29-Jun 7:00 AM ET)
Globe Newswire (Mon, 22-Jun 8:49 PM ET)
Market Chameleon (Tue, 28-Apr 7:47 AM ET)
Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Its drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne and select forms of cancer. Its second FASN inhibitor, TVB-3567, is a potent and selective small molecule FASN inhibitor in development for acne. It operates as a single business segment, developing and commercializing therapeutics for the treatment of MASH and other diseases where FASN plays a pathogenic role.
Sagimet Biosciences - Series A trades on the NASDAQ stock market under the symbol SGMT.
As of August 28, 2026, SGMT stock price declined to $10.55 with 538,807 million shares trading.
SGMT has a beta of 2.40, meaning it tends to be more sensitive to market movements. SGMT has a correlation of 0.20 to the broad based SPY ETF.
SGMT has a market cap of $655.77 million. This is considered a Small Cap stock.
In the last 3 years, SGMT traded as high as $20.71 and as low as $1.73.
The top ETF exchange traded funds that SGMT belongs to (by Net Assets): IWM, VTI, XBI, IWO, IBB.
SGMT has outperformed the market in the last year with a price return of +39.6% while the SPY ETF gained +19.7%. SGMT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +45.1% and 0.0%, respectively, while the SPY returned +2.2% and -0.9%, respectively.
SGMT support price is $10.15 and resistance is $11.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SGMT shares will trade within this expected range on the day.